Cargando…
Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
The incidence rate and mortality rate of cervical cancer have steadily increased in young women in China. Therefore, it is critical to improve HPV vaccination rates, particularly for the younger population. There are currently five types of prophylactic vaccines in China: bivalent HPV vaccine (AS04-...
Autores principales: | Li, Mingzhu, Zhao, Chao, Zhao, Yun, Li, Jingran, Wei, Lihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040563/ https://www.ncbi.nlm.nih.gov/pubmed/36993948 http://dx.doi.org/10.3389/fimmu.2023.1112750 |
Ejemplares similares
-
The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age
por: Zhao, Chao, et al.
Publicado: (2022) -
Age-Stratified Analysis of Vaginal Microbiota Dysbiosis and the Relationship with HPV Viral Load in HPV-Positive Women
por: Li, Mingzhu, et al.
Publicado: (2022) -
Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening
por: Li, Jingran, et al.
Publicado: (2022) -
Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus
por: Kash, Natalie, et al.
Publicado: (2015) -
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
por: Li, Zejun, et al.
Publicado: (2022)